Skip to main content
English
Deutsch
Español
Français
Log In
Log in
New user? Click here to register.
Have you forgotten your password?
Home
CRIS
Publication
SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances
Details
SF3B1 inhibition disrupts malignancy and prolongs survival in glioblastoma patients through BCL2L1 splicing and mTOR/ß-catenin pathways imbalances
ISSN
17569966
Date Issued
2022
Author(s)
JUAN SOLIVERA VELA
ANTONIO CARLOS FUENTES FAYOS
JUSTO PASTOR CASTAÑO FUENTES
JUAN MANUEL JIMÉNEZ VACAS
RAUL MIGUEL LUQUE HUERTAS
JESÚS MIGUEL PÉREZ GÓMEZ
MANUEL DAVID GAHETE ORTIZ
DOI
10.1186/s13046-022-02241-4
Subjects
Cancer Research
Oncology
